OUR TEAM

Mauro Mileni, PhD
Founder & Chief Executive Officer

Mauro Mileni, PhD
Founder & Chief Executive Officer

Michael Hanson, PhD
Chief Scientific Officer

Michael Hanson, PhD
Chief Scientific Officer

Joel Edwards, MBA
Chief Business Officer

Joel Edwards, MBA
Chief Business Officer

Jim Schmidt
Chief Financial Officer

Jim Schmidt
Chief Financial Officer

Christopher B. Roth, PhD
Vice President, Research

Christopher B. Roth, PhD
Vice President, Research

Alexander Alexandrov, PhD
Associate Director

Alexander Alexandrov, PhD
Associate Director

Karen Chiang, PhD
Research Scientist

Karen Chiang, PhD
Research Scientist

Roberto Jappelli, PhD
Principal Scientist

Roberto Jappelli, PhD
Principal Scientist

Sunghoon Kim, PhD
Research Scientist

Sunghoon Kim, PhD
Research Scientist

Le Li, PhD
Research Scientist

Le Li, PhD
Research Scientist

Kin Moy, BSc
Lab Manager/Research Associate

Kin Moy, BSc
Lab Manager/Research Associate
DIRECTORS OF THE BOARD

Daniel Bradbury
Director of the Board

Daniel Bradbury
Director of the Board

Michael Goguen
Director of the Board

Michael Goguen
Director of the Board

Mauro Mileni
Founder & CEO

Mauro Mileni
Founder & CEO

Rachel Tsunemoto Hislop
Observer

Rachel Tsunemoto Hislop
Observer
SCIENTIFIC ADVISORS

Tom Boone
Antibody Discovery and Development Advisor

Tom Boone
Antibody Discovery and Development Advisor

Prof. Tracy Handel, PhD
Pharmacology Advisor

Prof. Tracy Handel, PhD
Pharmacology Advisor

Anke Kretz-Rommel, PhD
Preclinical Development Advisor

Anke Kretz-Rommel, PhD
Preclinical Development Advisor

Fred Ramsdell, PhD
Oncology Advisor

Fred Ramsdell, PhD
Oncology Advisor

Laura Solforosi, PhD
Antibodies & Vaccines Advisor

Laura Solforosi, PhD
Antibodies & Vaccines Advisor
EXECUTIVE ADVISORS

Don Rindell
Managing Director of Camino International

Don Rindell
Managing Director of Camino International

Charlie Rodi, PhD
Founder and CEO of RhoDx, Inc.

Charlie Rodi, PhD
Founder and CEO of RhoDx, Inc.

R. Scott Struthers, PhD
CEO of Crinetics Pharmaceuticals

R. Scott Struthers, PhD
CEO of Crinetics Pharmaceuticals